Cytokeratin 18 levels, measured with the TPS test, also correlate to prostate cancer tumour load (Tarle et al, 1993), and pretreatment CK18-Asp396 levels correlate to tumour load in breast cancer patients (Ueno et al, 2003). This evidence concerns the gene KRT18 and neoplasm.